Guardant Health Inc (GH) Stock Forecast & Price Target
Guardant Health Inc · NASDAQ
$161.11-0.30 (-0.19%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 22 firms covering Guardant Health Inc, 22 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $110.00 to $215.00, a moderate spread. The average target of $181.95 sits 13% above the current $161.11. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.28 next quarter toward $-0.44 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS22 ratings
Strong Buy
Strong Buy00%
Buy22100%
Hold00%
Sell00%
Strong Sell00%
Based on 22 analysts giving stock ratings to Guardant Health Inc.
As of Sep, 22 of 22 firms rate GH a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
GH EPS & revenue forecast
EPS · NEXT QUARTER
$-0.28
Range $-0.57 – $-0.17 · 17 analysts · -44% YoY
Next period, 17 analysts expect Guardant Health Inc to earn $-0.28 a share (range $-0.57 – $-0.17), versus $-0.50 a year earlier. Full-year consensus is $-1.45, growing to $-0.44 the year after.
REVENUE · NEXT QUARTER
$369.7M
Range $364.0M – $380.4M · 17 analysts · +31% YoY
Revenue is expected to reach $369.7M (range $364.0M – $380.4M), +31.5% year-over-year. Full-year consensus is $1.4B, rising to $1.8B next year.
Top analysts covering Guardant Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GH.
#1
Anthony Petrone
Mizuho · Rank #86
Buy
$200.00+24.1% to target
Overall win rate
46%
+ Follow
#2
SJ
Sung Ji Nam
Scotiabank · Rank #140
Buy
$60.00-62.8% to target
Overall win rate
46%
+ Follow
#3
David Westenberg
Piper Sandler · Rank #244
Buy
$193.00+19.8% to target
Overall win rate
33%
+ Follow
#4
Luke Sergott
Barclays · Rank #246
Buy
$200.00+24.1% to target
Overall win rate
40%
+ Follow
#5
KM
Kyle Mikson
Canaccord Genuity · Rank #263
Buy
$205.00+27.2% to target
Overall win rate
34%
+ Follow
GH stock forecast FAQ
What is GH's average 12-month price target?+
The 22 analysts with a live target average $181.95 for Guardant Health Inc over the next 12 months, ranging from a $215.00 high to a $110.00 low.
Is GH stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 22 analyst ratings, 22 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for GH?+
The Street-high target is $215.00 (Citigroup), and the Street-low is $110.00 (UBS). The average of all 22 active targets is $181.95.
How many Wall Street analysts cover GH?+
22 analysts have an active rating on Guardant Health Inc, and 22 firms carry a live 12-month price target.
Who is the most accurate analyst covering GH?+
Among analysts who currently cover GH, Anthony Petrone of Mizuho has the strongest overall Quantellect track record (Rank #86). Their current call is Buy with a $200.00 target.
What is Guardant Health Inc's projected EPS for next quarter?+
The consensus estimate is $-0.28 per share (range $-0.57 – $-0.17) across 17 analysts. Full-year EPS is projected at $-1.45, rising to $-0.44 the following year.
How much revenue is Guardant Health Inc expected to report next quarter?+
Consensus revenue is $369.7M (range $364.0M – $380.4M). Full-year revenue is projected at $1.4B, growing to $1.8B next year.
Have analysts been upgrading or downgrading GH lately?+
As of Sep, 22 of 22 firms rate GH a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
